Voyager Therapeutics Inc

NASDAQ:VYGR 4:00:00 PM EDT

3.04

-0.16 (-5.00%)

5:57:27 PM EDT: $3.06 +0.02 (+0.66%)

Market Cap (Intraday)	168.22M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$9.91 Million
Adjusted EPS	-$0.53

See more estimates

10-Day MA	$3.09
50-Day MA	$3.22
200-Day MA	$4.82

See more pivots

Voyager Therapeutics Inc Stock, NASDAQ:VYGR

75 Hayden Avenue, Lexington, Massachusetts 02421

United States of America

Phone: +1.857.259.5340

Number of Employees: 162

http://www.voyagertherapeutics.com

Description

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.